A new Post-doctoral research position for NEUREKA is now open in LAAS-CNRS, Toulouse (France). Click here for more detais
Consortium
Funding
-
NEUREKA
A smart, hybrid neural-silico-computo device for drug discovery
A visionary and innovative hybrid technology, whereby nanoelectrodes and sophisticated computational models of neuronal circuits are combined to readout and manipulate activity/connectivity in cultured neuronal networks of Alzheimer’s disease, with subcellular accuracy
An H2020 Future and Emerging Technology
-
NEUREKA merges advanced computational modelling and high throughput nanoelectrodes into a powerful hybrid. The proposed merge allows the brain-mimicking control of activity and the realistic modelling of neural diseases in culture, thus leading the way for a new generation of dish trials